JPS6317889A - Germanium-alkali mixed salt of organic acid and production thereof - Google Patents
Germanium-alkali mixed salt of organic acid and production thereofInfo
- Publication number
- JPS6317889A JPS6317889A JP16314386A JP16314386A JPS6317889A JP S6317889 A JPS6317889 A JP S6317889A JP 16314386 A JP16314386 A JP 16314386A JP 16314386 A JP16314386 A JP 16314386A JP S6317889 A JPS6317889 A JP S6317889A
- Authority
- JP
- Japan
- Prior art keywords
- germanium
- organic acid
- alkali
- acid
- germanate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007524 organic acids Chemical class 0.000 title claims abstract description 27
- 239000003513 alkali Substances 0.000 title claims abstract description 24
- 150000003839 salts Chemical class 0.000 title claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 229910052732 germanium Inorganic materials 0.000 claims abstract description 27
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000002585 base Substances 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 abstract description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 15
- YBMRDBCBODYGJE-UHFFFAOYSA-N germanium oxide Inorganic materials O=[Ge]=O YBMRDBCBODYGJE-UHFFFAOYSA-N 0.000 abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 14
- PVADDRMAFCOOPC-UHFFFAOYSA-N oxogermanium Chemical compound [Ge]=O PVADDRMAFCOOPC-UHFFFAOYSA-N 0.000 abstract description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract description 12
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 5
- 229910052783 alkali metal Inorganic materials 0.000 abstract description 4
- 150000001340 alkali metals Chemical class 0.000 abstract description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract description 3
- 238000009835 boiling Methods 0.000 abstract description 3
- 239000001630 malic acid Substances 0.000 abstract description 3
- 235000011090 malic acid Nutrition 0.000 abstract description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- 201000011510 cancer Diseases 0.000 abstract description 2
- 238000013019 agitation Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
- 150000002291 germanium compounds Chemical class 0.000 description 9
- -1 organic acid germanium salt Chemical class 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- FNIHDXPFFIOGKL-UHFFFAOYSA-N disodium;dioxido(oxo)germane Chemical compound [Na+].[Na+].[O-][Ge]([O-])=O FNIHDXPFFIOGKL-UHFFFAOYSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000000862 absorption spectrum Methods 0.000 description 4
- 150000001447 alkali salts Chemical class 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000009257 reactivity Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- ZTYSLCVXCZXEBW-UHFFFAOYSA-K C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[Ge+3] Chemical compound C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[Ge+3] ZTYSLCVXCZXEBW-UHFFFAOYSA-K 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GWNAJLSPZNJDQW-UHFFFAOYSA-N [Na].[Ge] Chemical compound [Na].[Ge] GWNAJLSPZNJDQW-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940049920 malate Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004260 Potassium ascorbate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- RKTYLMNFRDHKIL-UHFFFAOYSA-N copper;5,10,15,20-tetraphenylporphyrin-22,24-diide Chemical compound [Cu+2].C1=CC(C(=C2C=CC([N-]2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3[N-]2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 RKTYLMNFRDHKIL-UHFFFAOYSA-N 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 150000007519 polyprotic acids Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000019275 potassium ascorbate Nutrition 0.000 description 1
- 229940017794 potassium ascorbate Drugs 0.000 description 1
- CONVKSGEGAVTMB-RXSVEWSESA-M potassium-L-ascorbate Chemical compound [K+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CONVKSGEGAVTMB-RXSVEWSESA-M 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 1
- VDNSGQQAZRMTCI-UHFFFAOYSA-N sulfanylidenegermanium Chemical compound [Ge]=S VDNSGQQAZRMTCI-UHFFFAOYSA-N 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- IEXRMSFAVATTJX-UHFFFAOYSA-N tetrachlorogermane Chemical compound Cl[Ge](Cl)(Cl)Cl IEXRMSFAVATTJX-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、有機酸のゲルマニウム・アルカリ混合塩およ
びその製法に関する。更に詳しくは、市販のゲルマニウ
ム化合物の中でも取扱容易な酸化ゲルマニウムからゲル
マン酸アルカリを得、それから高収率で容易に有用な有
機酸のゲルマニウム・アルカリ混合塩を製造する方法お
よび該方法によって製造された有機酸のゲルマニウム・
アルカリ混合塩に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a germanium-alkali mixed salt of an organic acid and a method for producing the same. More specifically, a method for obtaining an alkali germanate from germanium oxide, which is easy to handle among commercially available germanium compounds, and then producing a germanium-alkali mixed salt of an organic acid that is easily useful in high yield, and a method for producing a germanium-alkali mixed salt of an organic acid that is easily useful in high yield. Organic acid germanium
Regarding alkaline mixed salts.
[従来技術]
近年、ゲルマニウムが、癌その他の治療困難な疾病の治
療に有効であると云われ、これに関して、既に多くの著
書が出版されている。例えば浅井−彦博士著「ゲルマニ
ウムと私」、山崎敏子医師著「ゲルマニウムの健康法」
、甲斐良−氏著「ゲルマニウム療法」等、すべて現代医
学では治療困難とされている疾病にゲルマニウム化合物
が奇跡的な効果をあられすことが述べられている。[Prior Art] In recent years, germanium is said to be effective in treating cancer and other difficult-to-treat diseases, and many books have already been published on this subject. For example, “Germanium and Me” by Dr. Hiko Asai, “Germanium Health Method” by Dr. Toshiko Yamazaki
, ``Germanium Therapy,'' by Mr. Kai Ryo, etc., all describe the miraculous effects of germanium compounds on diseases that are considered difficult to treat with modern medicine.
また、昔からこの様な!I病に有効であると云い伝えら
れて来た薬草の成分としてゲルマニウム化合物が最も効
力に関与していたのではないかとも云われている。しか
しながら、現在栽培によって得られる薬草の中にはゲル
マニウム化合物が殆ど含まれていない。従って、培地に
ゲルマニウム化合物を混入することによって薬草の中に
以前と同様にゲルマニウム化合物を含有させるようにす
る研究も多くなされたが、植物は無機ゲルマニウムを利
用できないので、EDTA等との有機キレートを作って
吸収させているけれども、ゲルマニウムの利用効率はあ
まり高くない。Also, it's been like this for a long time! It is also said that germanium compounds are the components of medicinal herbs that have been said to be effective against I disease and are most responsible for their efficacy. However, medicinal herbs currently obtained through cultivation contain almost no germanium compounds. Therefore, many studies have been conducted to make medicinal herbs contain germanium compounds by mixing germanium compounds into the culture medium, but since plants cannot use inorganic germanium, organic chelates with EDTA etc. have been used. Although germanium is produced and absorbed, the utilization efficiency of germanium is not very high.
一般にはゲルマニウム化合物は、化学反応性が低いため
利用し難いことが大きな欠点である。例えば、酸化ゲル
マニウムや硫化ゲルマニウムは、何れも水に不溶性であ
るため、植物や動物によって吸収利用され難く、また有
機キレートを作ることができても、水溶液中での錯生成
平衡に於ける有効安定度が小さいので、植物に吸収利用
される率が低い。Generally, a major drawback of germanium compounds is that they are difficult to utilize due to their low chemical reactivity. For example, germanium oxide and germanium sulfide are both insoluble in water, so they are difficult to be absorbed and utilized by plants and animals, and even if organic chelates can be made, they do not have effective stability in the complexation equilibrium in aqueous solutions. Since the concentration is small, the rate at which it is absorbed and utilized by plants is low.
メンデレーエフが元素の周期律表を考案した項には、ゲ
ルマニウムは未発見であったので、ゲルマニウムの位置
の空欄に二カ珪素と仮称する元素を想定した話しは有名
である。これはゲルマニウムの化学反応性が低いため、
地殻に於ける分布は広いにも拘わらず、鉱石からの抽出
、分離が当時の技術では出来ず、発見が遅れたことによ
るものである。It is well known that in the section where Mendeleev devised the periodic table of elements, germanium had not yet been discovered, so he assumed an element tentatively named dikasilicon in the blank space for germanium. This is because germanium has low chemical reactivity.
Despite its wide distribution in the earth's crust, it was not possible to extract or separate it from ore using the technology available at the time, and its discovery was delayed.
[発明の目的と構成]
本発明者は、上述の如くヌ応性の低いゲルマニウムを有
機酸と反応せしめるため、ゲルマニウムが両性元素であ
ることに着目し、先づアニオンとしてのゲルマニウム化
合物であるゲルマン酸のアルカリ塩水溶液を作り、これ
に有機酸を加えることによりpHをアルカリ性から酸性
に移行させることによって、−旦アニオンとして水に溶
けたゲルマニウムを容易にカチオンに変化させ、有機酸
ゲルマニウム塩を生成せしめると同時に、有機酸のカル
ボキシル基の3分の1をアルカリ塩にすることによって
、安定なゲルマニウムとアルカリの混合塩を一挙に合成
することに成功したものである。[Objective and Structure of the Invention] In order to react germanium, which has low reactivity as described above, with an organic acid, the present inventor focused on the fact that germanium is an amphoteric element, and first reacted germanic acid, which is a germanium compound, as an anion. By making an aqueous alkaline salt solution and adding an organic acid to it to shift the pH from alkaline to acidic, germanium, which was previously dissolved in water as an anion, is easily changed to a cation, producing an organic acid germanium salt. At the same time, by converting one-third of the carboxyl groups of organic acids into alkali salts, they succeeded in synthesizing a stable mixed salt of germanium and alkali all at once.
例えばアルカリとして水酸化ナトリウムを使用し、有機
酸としてクエン酸を使った場合の反応を推測すれば、次
の通りである。For example, the reaction when using sodium hydroxide as the alkali and citric acid as the organic acid is as follows.
aO
aO
H,C−C0OH
→ HO−C−COO0OC−C−OHHtC−CO
ONa Na00C−CH2この場合、クエン酸ゲル
マニウム・ナトリウムを10〜30%含む水溶液が容易
に得られ、蒸発乾個すれば4〜2分子の結晶水を持つ白
色結晶が得られる。aO aOH H,C-C0OH → HO-C-COO0OC-C-OHHtC-CO
ONa Na00C-CH2 In this case, an aqueous solution containing 10 to 30% germanium sodium citrate is easily obtained, and upon evaporation to dryness, white crystals having 4 to 2 molecules of water of crystallization are obtained.
もし本発明によらず、酸化ゲルマニウムとクエン酸を、
水中で加熱撹拌した場合、長時間煮沸を継続しても酸化
ゲルマニウムは殆ど未反応のま\沈澱として残り、クエ
ン酸ゲルマニウムは得られない。If germanium oxide and citric acid are not in accordance with the present invention,
When heated and stirred in water, germanium oxide remains almost unreacted as a precipitate even if boiling is continued for a long time, and germanium citrate cannot be obtained.
ゲルマニウムの供給源としては、他に四塩化ゲルマニウ
ムや金属ゲルマニウム等が考えられる。Other possible sources of germanium include germanium tetrachloride and germanium metal.
しかし、前者は容易に塩素を放すため、空気中で塩化水
素ガスの白煙を発生する取扱困難な液体で、しかも有機
酸水溶液に加えると直ちに加水分解して酸化ゲルマニウ
ムの沈澱を生ずる。また、後者は全く反応せず、長時間
加熱しても変化しない。However, since the former easily releases chlorine, it is a difficult liquid to handle as it generates white smoke of hydrogen chloride gas in the air, and furthermore, when added to an aqueous organic acid solution, it immediately hydrolyzes to form a precipitate of germanium oxide. Moreover, the latter does not react at all and does not change even when heated for a long time.
酸化ゲルマニウムは市販のものでもよく、通常は斜方晶
形の結晶性粉末または無定形粉末である。Germanium oxide may be commercially available and is usually an orthorhombic crystalline powder or an amorphous powder.
このような酸化ゲルマニウム粉末中に反応性の悪い正方
晶形の結晶が混在する場合があるが、これを沈澱として
分離し、過酸化ナトリウム水溶液に溶解すると、ゲルマ
ン酸ナトリウムを生ずるので、それを本発明の製法に使
用することができる。Such germanium oxide powder may contain tetragonal crystals with poor reactivity, but when these are separated as precipitates and dissolved in an aqueous sodium peroxide solution, sodium germanate is produced. It can be used in the production method.
本発明においてゲルマン酸アルカリを製造する為に酸化
ゲルマニウムと反応させるアルカリとしては、ナトリウ
ム、カリウム等のアルカリ金属、アルカリ土類金属、ア
ンモニアの水酸化物かが適当である。In the present invention, suitable alkalis to be reacted with germanium oxide to produce alkali germanates include hydroxides of alkali metals such as sodium and potassium, alkaline earth metals, and ammonia.
有機酸としては、クエン酸、リンゴ酸、酒石酸、こはく
酸、乳酸、リノール酸、リルイン酸、酪酸、酢酸、アス
コルビン酸等、食品成分として知られている有機酸から
1種また2種以上を選んで用いることかできる。As the organic acid, select one or more organic acids known as food ingredients, such as citric acid, malic acid, tartaric acid, succinic acid, lactic acid, linoleic acid, lyluic acid, butyric acid, acetic acid, and ascorbic acid. It can be used in
本発明により得られる生成物では、ゲルマニウム有機酸
塩の中にアルカリ塩が混在し、または多塩基性酸の場合
にはゲルマニウムと同一の有機酸分子内の他のカルボキ
シル基とアルカリが結合しているのが一つの特徴である
。このような化学構造では、アルカリ成分の解離恒数が
大きいので、アルカリ塩の部分が水中で強く解離し、そ
の影響でゲルマニウム結合部分の解離が抑えらる。それ
故、生成物の無機化を抑制でき、生成物は有機化したゲ
ルマニウムとして働くので、生物、特に植物への吸収利
用率が高くなっており、健康上有用なゲルマニウム化合
物としてアルカリ塩の共存が好結果を生じている。In the product obtained by the present invention, an alkali salt is mixed in the germanium organic acid salt, or in the case of a polybasic acid, an alkali is bonded to other carboxyl groups in the same organic acid molecule as germanium. One of the characteristics is that In such a chemical structure, the dissociation constant of the alkali component is large, so the alkali salt portion is strongly dissociated in water, and this suppresses the dissociation of the germanium bonding portion. Therefore, the mineralization of the product can be suppressed, and the product acts as organic germanium, so the rate of absorption and utilization by living things, especially plants, is high, and the coexistence of alkali salts is a germanium compound that is useful for health. It is producing good results.
酸化ゲルマニウムとアルカリ成分の反応は、水中で両成
分を加熱、撹拌するだけでよく、ゲルマン酸アルカリが
水溶液の形で得られる。この水溶液をそのまま、有機酸
との反応に用いることができる。The reaction between germanium oxide and the alkali component can be carried out by simply heating and stirring both components in water, and an alkali germanate can be obtained in the form of an aqueous solution. This aqueous solution can be used as it is for reaction with an organic acid.
ゲルマン酸アルカリと有機酸の反応は、上記のようにし
て調製したゲルマン酸アルカリの水溶液に有機酸を所定
の割合で加えればよい。反応は、常温で行ってらよいが
、加熱撹拌下に行うのが好ましい。ゲルマン酸アルカリ
1モル当たり、6塩基当量の有機酸が反応するが、有機
酸の使用量は、6塩基当量より多くてもよい。The reaction between the alkali germanate and the organic acid can be carried out by adding the organic acid at a predetermined ratio to the aqueous solution of the alkali germanate prepared as described above. Although the reaction may be carried out at room temperature, it is preferably carried out under heating and stirring. Six base equivalents of organic acid are reacted per mole of alkali germanate, but the amount of organic acid used may be greater than six base equivalents.
次に実施例を示し、本発明を具体的に説明する。Next, examples will be shown to specifically explain the present invention.
実施例1
クエン酸ゲルマニウム・ナトリウムの製造ニー水酸化ナ
トリウム8gを水2001を溶解し、これに酸化ゲルマ
ニウム10.46gを加えて撹拌煮沸して、ゲルマン酸
ナトリウムの水溶液を得る。Example 1 Production of germanium sodium citrate 8 g of sodium hydroxide is dissolved in 200 ml of water, 10.46 g of germanium oxide is added thereto, and the mixture is stirred and boiled to obtain an aqueous solution of sodium germanate.
この水溶液にクエン酸42gを加え、撹拌煮沸して透明
水溶液を得る。透明水溶液を、−夜凍結乾燥することに
より、白色結晶生成物57gを得た。以下にこの結晶生
成物の分析値を示す。42 g of citric acid is added to this aqueous solution, and the mixture is stirred and boiled to obtain a transparent aqueous solution. The clear aqueous solution was freeze-dried overnight to obtain 57 g of white crystalline product. The analytical values of this crystalline product are shown below.
元素分析: C、H分析 C: 26.0%、H: 3.5%。Elemental analysis: C,H analysis C: 26.0%, H: 3.5%.
発光分析 Ge: 13.0%。Luminescence analysis Ge: 13.0%.
白色結晶生成物の構造式を
Ge(CsHsOtNa)t−3HtOとして、上記実
測値と計算値とを比較すると、次の通りほぼ一致した。Assuming that the structural formula of the white crystalline product is Ge(CsHsOtNa)t-3HtO, when the above-mentioned measured values and calculated values are compared, they almost match as follows.
C(%) H(%) Ge(%)計算値:26.
0 2.9 13.2実測値: 26.0 3.
5 13.0生成物の赤外吸収スペクトルを第1図に
示す。C (%) H (%) Ge (%) Calculated value: 26.
0 2.9 13.2 Actual value: 26.0 3.
The infrared absorption spectrum of the 513.0 product is shown in FIG.
実施例2
アスコルビン酸ゲルマニウム・カリウムの製造酸化ゲル
マニウム52.3g (0,5モル)を、約lO%の水
酸化カリウム水溶液561g(水酸化カリウム1モル)
の中に撹拌しながら加え、煮沸溶解した後、水で全量を
約2Qに希釈する。冷却後、アスコルビン酸528gを
加え、撹拌して無色透明な水溶液を得、次いで水で全f
fi3630m(2に希釈する。この液1m&中にゲル
マニウム10mgとアスコルビン酸145mgが含有さ
れていた。Example 2 Production of germanium/potassium ascorbate 52.3 g (0.5 mol) of germanium oxide was added to 561 g (1 mol potassium hydroxide) of an approximately 10% potassium hydroxide aqueous solution.
Add to the solution while stirring, boil and dissolve, then dilute the total amount with water to about 2Q. After cooling, 528 g of ascorbic acid was added and stirred to obtain a colorless and transparent aqueous solution.
fi3630m (diluted to 2.1 m of this solution contained 10 mg of germanium and 145 mg of ascorbic acid.
実施例3
リンゴ酸ゲルマニウム・ナトリウムの製造ニー水酸化ナ
トリウム8gを水200m(を溶解し、これに酸化ゲル
マニウムl O,5gを加えて懸濁液を得る。この懸濁
液を、約30分間加熱沸騰せしめてゲルマン酸ナトリウ
ム水溶液とした後、リンゴ酸(C4HI05)40gを
熱水200m&に溶解した水溶液に撹拌しながら加え、
更に30分間煮沸して透明液を得る。これを蒸発乾個し
て、約55gの結晶性粉末を得た。Example 3 Production of sodium germanium malate Dissolve 8 g of sodium hydroxide in 200 m of water and add 5 g of germanium oxide to obtain a suspension. This suspension is heated for about 30 minutes. After boiling to obtain an aqueous solution of sodium germanate, add 40 g of malic acid (C4HI05) to an aqueous solution of 200 m of hot water with stirring.
Boil for another 30 minutes to obtain a clear liquid. This was evaporated to dryness to obtain about 55 g of crystalline powder.
この結晶1g中にはゲルマニウム132+++gが含有
されていた。結晶性粉末の赤外吸収スペクトルを第2図
に示す。1 g of this crystal contained 132+++ g of germanium. Figure 2 shows the infrared absorption spectrum of the crystalline powder.
実施例4
乳酸ゲルマニウム・ナトリウムの製造ニー実施例3の方
法で調製したゲルマン酸ナトリウム水溶液(約100m
(り中に、70%乳酸水溶液96gを加え、撹拌均一化
した後、水で726mCに希釈すると、1mf7にゲル
マニウム10mgを含有する乳酸ゲルマニウムナトリウ
ムの水溶液が得られる。Example 4 Production of sodium germanium lactate A sodium germanate aqueous solution (approximately 100 m
(96 g of a 70% lactic acid aqueous solution is added to the solution, stirred and homogenized, and then diluted to 726 mC with water to obtain an aqueous solution of sodium germanium lactate containing 10 mg of germanium per mf7.
実施例5
酢酸ゲルマニウム・ナトリウムの製造ニー実施例3の方
法で調製したゲルマン酸ナトリウム水溶液(約100i
(1)中に水酢醗36gを加え、撹拌均一化した後、水
で363mQに希釈するとImQ中にゲルマニウム20
mgを含有する酢酸ゲルマニウム・ナトリウムの水溶液
が得られる。Example 5 Production of sodium germanium acetate A sodium germanate aqueous solution prepared by the method of Example 3 (approximately 100 i
Add 36g of water vinegar to (1), stir to homogenize, and then dilute to 363mQ with water.
An aqueous solution of sodium germanium acetate is obtained containing mg of sodium germanium acetate.
第1図は、実施例1で得られたクエン酸ゲルマニウム・
ナトリウムの赤外吸収スペクトル、第2図は、実施例3
で得られたリンゴ酸ゲルマニウム・ナトリウムの赤外吸
収スペクトルである。Figure 1 shows the germanium citrate obtained in Example 1.
Infrared absorption spectrum of sodium, Figure 2 is Example 3
This is an infrared absorption spectrum of sodium germanium malate obtained in .
Claims (1)
マニウム・アルカリ混合塩。 2、ゲルマン酸アルカリ1モル当たり有機酸6塩基当量
から成る特許請求の範囲第1項記載のゲルマニウム・ア
ルカリ混合塩。 3、ゲルマン酸アルカリと有機酸を反応させることを特
徴とする有機酸のゲルマニウム・アルカリ混合塩の製法
。 4、ゲルマン酸アルカリ1モル当たり有機酸少なくとも
6塩基当量を反応させる特許請求の範囲第3項記載の製
法。[Claims] 1. A germanium-alkali mixed salt of an organic acid consisting of an alkali germanate and an organic acid. 2. The germanium-alkali mixed salt according to claim 1, which comprises 6 base equivalents of organic acid per mole of alkali germanate. 3. A method for producing a germanium/alkali mixed salt of an organic acid, which is characterized by reacting an alkali germanate with an organic acid. 4. The method according to claim 3, wherein at least 6 base equivalents of organic acid are reacted per mole of alkali germanate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16314386A JPS6317889A (en) | 1986-07-10 | 1986-07-10 | Germanium-alkali mixed salt of organic acid and production thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16314386A JPS6317889A (en) | 1986-07-10 | 1986-07-10 | Germanium-alkali mixed salt of organic acid and production thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6317889A true JPS6317889A (en) | 1988-01-25 |
Family
ID=15768031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16314386A Pending JPS6317889A (en) | 1986-07-10 | 1986-07-10 | Germanium-alkali mixed salt of organic acid and production thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6317889A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3212817A1 (en) * | 1982-04-06 | 1983-10-13 | Sanum-Kehlbeck GmbH & Co KG, 2812 Hoya | PHARMACEUTICALLY EFFECTIVE ORGANIC GERMANIUM COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
JPS6084295A (en) * | 1983-10-15 | 1985-05-13 | Masato Akutsu | Novel germanium compound and its production |
-
1986
- 1986-07-10 JP JP16314386A patent/JPS6317889A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3212817A1 (en) * | 1982-04-06 | 1983-10-13 | Sanum-Kehlbeck GmbH & Co KG, 2812 Hoya | PHARMACEUTICALLY EFFECTIVE ORGANIC GERMANIUM COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
JPS6084295A (en) * | 1983-10-15 | 1985-05-13 | Masato Akutsu | Novel germanium compound and its production |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5504055A (en) | Metal amino acid chelate | |
JPS5942683B2 (en) | Essential metal ion complex | |
CN102149393B (en) | Antimicrobial silver solutions | |
CN106187797A (en) | Preparation method of ferrous glycinate complex | |
ES2418654T3 (en) | Metal complexes: their use for the preparation of compositions for agricultural use | |
KR101683150B1 (en) | Method of manufacturing calcium citrate with high degree of electrolytic dissociation | |
Liu et al. | The Stereochemistry of Complex Inorganic Compounds. XXVII. Asymmetric Syntheses of Tris (bipyridine) Complexes of Ruthenium (II) and Osmium (II) | |
CN109369478A (en) | A kind of synthetic method of zinc methionine chelate | |
US9845284B1 (en) | Method of obtaining complex acidic salts of divalent metals and dicarboxylic acids | |
KR20190086145A (en) | Preparation method of the high activated calcium by sonochemistry | |
CN107216409A (en) | A kind of preparation method of chitosan L malic acid rare earth compoundings | |
CN113272255B (en) | Silicon ion complex organized with carboxylic acid, method for preparing the same, and product using the same | |
US3091626A (en) | Method of making ferrous citrate | |
JPS6317889A (en) | Germanium-alkali mixed salt of organic acid and production thereof | |
JPWO2018003531A1 (en) | Pyrroloquinoline quinone monosodium, method for producing the same, and composition containing the same | |
JPS63225332A (en) | Solid lactate and production thereof | |
KR101729965B1 (en) | Method of manufacturing calcium oxide with high degree of electrolytic dissociation | |
CN110776416A (en) | Preparation method of iron glucoheptonate | |
US2260870A (en) | Medicinal preparation | |
GB827521A (en) | New organic copper compounds and solutions and mixtures containing the same, and processes for the preparation of such compounds | |
CN1086713A (en) | Margarita calcium and preparation method | |
SU1416097A1 (en) | Method of producing defoliant | |
CN1265924A (en) | Preparation process of iodine-125 seed source carrier rod | |
JPS6317891A (en) | Production of glucide germanium complex | |
SU1414776A1 (en) | Method of producing copper hydroxophosphate |